Cochrane Collaboration risk of O157, ova and parasites loperamide prior to procedure. bias assessment: uncertain risk of (including general bias. microscopy, acid-fast Prokinetics: Nil. staining, and/or antigen testing for Giardia, Time before CDI treatment was Cryptosporidium, Isospora, stopped before FMT: Patients were and Microsporidia), C required to discontinue all difficile, and Helicobacter antibiotics at least 48 hours prior to pylori antigen. the procedure.
Cochrane Collaboration risk of bias assessment: uncertain risk of bias. O157, ova and parasites (including general microscopy, acid-fast staining, and/or antigen testing for Giardia, Cryptosporidium, Isospora, and Microsporidia), C difficile, and Helicobacter pylori antigen. loperamide prior to procedure. Prokinetics: Nil. Time before CDI treatment was stopped before FMT: Patients were required to discontinue all antibiotics at least 48 hours prior to the procedure.
fmt-appendices-a-e.docx